The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus

被引:145
|
作者
Bos, ECW
Luytjes, W
VanderMeulen, H
Koerten, HK
Spaan, WJM
机构
[1] LEIDEN STATE UNIV,DEPT VIROL,2300 AH LEIDEN,NETHERLANDS
[2] LEIDEN STATE UNIV,LAB ELECTRON MICROSCOPY,2300 AH LEIDEN,NETHERLANDS
关键词
D O I
10.1006/viro.1996.0165
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have studied the production and release of infectious DI-particles in vaccinia-T7-polymerase recombinant virus-infected L cells that were transfected with five different plasmids expressing the synthetic DI RNA MIDI-HD and the four structural proteins (M, N, S, and E) of the murine coronavirus MHV-A59. The DI cDNA contains the hepatitis delta ribozyme sequences to generate in the transfected cells a defined 3' end. In EM studies of transfected cells virus-like particles (VLP) were observed in vesicles. Release of the particles into the medium was studied by immunoprecipitations of proteins released into the culture supernatant Particle release was independent of S or N, but required M and E. Coexpression of E and M was sufficient for particle release. Coexpression of the structural proteins and the MIDI-HD RNA resulted in the production and release of infectious DI-particles. Infectivity of the DI-particles was determined by adding helper virus MHV-A59 to the medium containing the VLPs and using this mixture to infect new L cells. Intracellular RNA of several subsequent undiluted passages was isolated to detect the MIDI-HD RNA. Passage of the MIDI-HD RNA was dependent on the expression of the structural proteins of MHV-A59 in the transfected cells. In the absence of either E or M, MIDI-HD RNA could not be passaged to fresh L cells. We have thus developed a system in which we can produce coronavirus-like particles and an assay to test their infectivity. (C) 1996 Academic Press, Inc.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 50 条
  • [31] MURINE LEUKEMIA-VIRUS INFECTIOUS CENTERS ARE DEPENDENT ON RATE OF VIRUS PRODUCTION BY INFECTED-CELLS
    CHESEBRO, B
    WEHRLY, K
    WATSON, K
    CHESEBRO, K
    VIROLOGY, 1978, 84 (01) : 222 - 226
  • [32] Formation of infectious pancreatic necrosis virus-like particles following expression of segment A by recombinant Semliki Forest virus
    McKenna, BM
    Fitzpatrick, RM
    Phenix, KV
    Todd, D
    Vaughan, LM
    Atkins, GJ
    MARINE BIOTECHNOLOGY, 2001, 3 (02) : 103 - 110
  • [33] The Intracellular Cargo Receptor ERGIC-53 Is Required for the Production of Infectious Arenavirus, Coronavirus, and Filovirus Particles
    Klaus, Joseph P.
    Eisenhauer, Philip
    Russo, Joanne
    Mason, Anne B.
    Do, Danh
    King, Benjamin
    Taatjes, Douglas
    Cornillez-Ty, Cromwell
    Boyson, Jonathan E.
    Thali, Markus
    Zheng, Chunlei
    Liao, Lujian
    Yates, John R., III
    Zhang, Bin
    Ballif, Bryan A.
    Botten, Jason W.
    CELL HOST & MICROBE, 2013, 14 (05) : 522 - 534
  • [34] Production of Japanese encephalitis virus-like particles by recombinant insect cells
    Yamaji, Hideki
    Takahashi, Yusuke
    Nakamura, Masataka
    Katsuda, Tomohisa
    Kuwahara, Miwa
    Konishi, Eiji
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 108 : S7 - S7
  • [35] Production of influenza virus-like particles using recombinant insect cells
    Matsuda, Takuya
    Tanijima, Toshikazu
    Hirose, Akito
    Masumi-Koizumi, Kyoko
    Katsuda, Tomohisa
    Yamaji, Hideki
    BIOCHEMICAL ENGINEERING JOURNAL, 2020, 163 (163)
  • [36] Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus
    Lv, Lishan
    Li, Xiaoming
    Liu, Genmei
    Li, Ran
    Liu, Qiliang
    Shen, Huifang
    Wang, Wei
    Xue, Chunyi
    Cao, Yongchang
    JOURNAL OF VETERINARY SCIENCE, 2014, 15 (02) : 209 - 216
  • [37] Elucidation of Minimal Adenoviral Helper DNA Sequences Essential for Recombinant Adeno-Associated Virus Production
    Doshi, Jiten
    Staiti, Jillian
    Sanmiguel, Julio C.
    Vandenberghe, Luk H.
    Zabaleta, Nerea
    MOLECULAR THERAPY, 2023, 31 (04) : 631 - 631
  • [38] Method to decrease the titers of contaminating helper adenovirus during the production of recombinant adeno-associated virus
    Zaratiegui, M
    Narvaiza, I
    Qian, C
    Novo, FJ
    BIOTECHNIQUES, 2000, 28 (06) : 1096 - +
  • [39] PRODUCTION OF A HELPER-FREE RECOMBINANT ADENOASSOCIATED VIRUS THAT HARBORS HUMAN BETA-GLOBIN CDNA
    SITARIC, S
    WEBB, MS
    OHI, S
    FASEB JOURNAL, 1991, 5 (06): : A1550 - A1550
  • [40] MURINE T-HELPER CELL IMMUNE-RESPONSE TO RECOMBINANT VACCINIA VENEZUELAN EQUINE ENCEPHALITIS-VIRUS
    MATHEWS, JH
    KINNEY, RM
    ROEHRIG, JT
    BARRETT, ADT
    TRENT, DW
    VACCINE, 1994, 12 (07) : 620 - 624